Literature DB >> 19230427

Diagnostic yield of fluoroscopy-guided transbronchial lung biopsy in non-endobronchial lung lesion.

Warangkana Rittirak1, Suree Sompradeekul.   

Abstract

BACKGROUND: Parenchymatous lung lesions often present as peripheral non-endobronchial lesions, which are not visible through conventional flexible fiberoptic bronchoscopy. Tissue diagnosis from these lesions is usually obtained by transbronchial lung biopsy (TBLB). The lesion location is estimated by chest radiograph (CXR) or computerized tomography (CT) of the chest. The diagnostic yield of TBLB is limited and variable, ranging from 16-80%. Fluoroscopy is used simultaneously with FOB during TBLB for better localization of parenchymatous lesions. Nevertheless, fluoroscopy-guided transbronchial biopsy (Flu-TBLB) is not widely used at present. The advantages and safety of Flu-TBLB have not yet been verified.
OBJECTIVE: To compare the diagnostic yields and complications of TBLB with and without fluoroscopy guidance for non-endobronchial lung lesion. STUDY
DESIGN: Descriptive study with subgroup analysis. MATERIAL AND
METHOD: Medical and bronchoscopic data records of patients who underwent TBLB at Siriraj Hospital from January 2001 to June 2005 were reviewed. The patients were divided into two groups according to the use of fluoroscopy during TBLB. Patient demographic data, underlying diseases, CXR findings, diagnoses, complications and yields of TBLB of the two groups were compared. STATISTICAL ANALYSIS: Student t-test and chi-square test.
RESULTS: Six hundred and fifty patients were included in the present study. Three hundred and thirty-one patients were in Flu-TBLB group, 319 patients were in non fluoroscopy-guided transbronchial biopsy (NFlu-TBLB) group. The overall diagnostic yield of Flu-TBLB group was statistically significantly higher than NFlu-TBLB group (43.8% vs. 32.9%; p = 0.003). When comparing the diagnostic yields of the 2 groups by CXR findings, the yields of Flu-TBLB group were statistically significantly higher than NFlu-TBLB group for lung masses (41.4% vs. 29.5%; p = 0.036) and focal infiltrative lesions (46.2% vs. 29.4%; p = 0.008), respectively. The yield of Flu-TBLB group was slightly higher than NFlu-TBLB group for diffuse infiltrative lesion (45.1% vs. 40%; p = 0.289). No significant difference in the rate of pneumothorax discovery between the two groups (1.2% in Flu-TBLB group and 0.6% in NFlu-TBLB group) was observed.
CONCLUSION: Flu-TBLB significantly increases the diagnostic yields of non-endobronchial lung masses and focal infiltrates compared to NFlu-TBLB. There is no clinical significant difference in the rate of pneumothorax discovery between the two groups. Flu-TBLB is also more cost-saving.

Entities:  

Mesh:

Year:  2007        PMID: 19230427

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  8 in total

1.  The Effect of Using Different Types of Forceps in the Efficacy of Transbronchial Lung Biopsy.

Authors:  Abdulrahman Almadani; Melissa N Y Ping; Anu Deenadayalu; Jean Saunders; Aidan O'Brien
Journal:  Lung       Date:  2018-11-15       Impact factor: 2.584

2.  Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial.

Authors:  Jonathan A Galli; Nicholas L Panetta; Nathaniel Gaeckle; Fernando J Martinez; Bethany Moore; Thomas Moore; Anthony Courey; Kevin Flaherty; Gerard J Criner
Journal:  Lung       Date:  2017-06-16       Impact factor: 2.584

3.  Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

Authors:  Nishant Gupta; Geraldine A Finlay; Robert M Kotloff; Charlie Strange; Kevin C Wilson; Lisa R Young; Angelo M Taveira-DaSilva; Simon R Johnson; Vincent Cottin; Steven A Sahn; Jay H Ryu; Kuniaki Seyama; Yoshikazu Inoue; Gregory P Downey; MeiLan K Han; Thomas V Colby; Kathryn A Wikenheiser-Brokamp; Cristopher A Meyer; Karen Smith; Joel Moss; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

4.  Small lung lesions invisible under fluoroscopy are located accurately by three-dimensional localization technique on chest wall surface and performed bronchoscopy procedures to increase diagnostic yields.

Authors:  Chaosheng Deng; Xiaoming Cao; Dawen Wu; Haibo Ding; Ruixiong You; Qunlin Chen; Linying Chen; Xin Zhang; Qiaoxian Zhang; Yongquan Wu
Journal:  BMC Pulm Med       Date:  2016-11-29       Impact factor: 3.317

5.  Factors Related to the Diagnostic Yield of Flexible Bronchoscopy without Guidance in Bronchoscopically Invisible Peripheral Lung Lesions.

Authors:  Hye Seon Kang; Jick Hwan Ha; Hyeon Hui Kang; Chang Dong Yeo; Chin Kook Rhee; Sung Kyoung Kim; Hwa Sik Moon; Sang Haak Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-07-03

6.  Transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: the severity of cystic lung destruction assessed by the modified Goddard scoring system as a predictor for establishing the diagnosis.

Authors:  Shouichi Okamoto; Kazuhiro Suzuki; Takuo Hayashi; Keiko Muraki; Tetsutaro Nagaoka; Koichi Nishino; Yasuhito Sekimoto; Shinichi Sasaki; Kazuhisa Takahashi; Kuniaki Seyama
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

7.  Feasibility of a prototype carbon nanotube enabled stationary digital chest tomosynthesis system for identification of pulmonary nodules by pulmonologists.

Authors:  Allen Cole Burks; Jason Akulian; Christina R MacRosty; Sohini Ghosh; Adam Belanger; Muthu Sakthivel; Thad S Benefield; Christina R Inscoe; Otto Zhou; Jianping Lu; Yueh Z Lee
Journal:  J Thorac Dis       Date:  2022-02       Impact factor: 2.895

Review 8.  Advances in diagnostic interventional pulmonology.

Authors:  Nassar Al-Zubaidi; Ayman O Soubani
Journal:  Avicenna J Med       Date:  2015 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.